Biopharmaceutics Classification System and In Vitro-In Vivo Correlation
The Biopharmaceutics Classification System The biopharmaceutics classification system categorises drug substances into four classes according to their...
The Biopharmaceutics Classification System
The biopharmaceutics classification system categorises drug substances into four classes according to their aqueous solubility and intestinal permeability. Class One drugs exhibit high solubility and high permeability and generally show excellent oral bioavailability with dissolution rarely limiting absorption. Class Two drugs exhibit low solubility but high permeability, such that dissolution rate is frequently the rate-limiting step governing oral absorption, making dissolution testing particularly predictive of in vivo performance for this class. Class Three drugs exhibit high solubility but low permeability, with absorption limited by membrane transport rather than dissolution, while Class Four drugs exhibit both low solubility and low permeability and present the greatest formulation and bioavailability challenges.
In Vitro-In Vivo Correlation
In vitro-in vivo correlation describes a predictive mathematical relationship between an in vitro dissolution property and an in vivo response, most commonly the fraction of drug absorbed, and where established, allows dissolution data to serve as a surrogate for bioequivalence studies, particularly valuable for extended-release formulations undergoing post-approval manufacturing changes. Level A correlation, representing a point-to-point relationship between the entire in vitro dissolution and in vivo absorption profiles, offers the greatest regulatory and biowaiver value, while level B and level C correlations, based on statistical moments or a single dissolution and pharmacokinetic parameter respectively, provide comparatively limited predictive utility.
Recent Advances, Artificial Intelligence Applications, and Future Scope
Physiologically based biopharmaceutics modelling, integrating dissolution data with physiological parameters of the gastrointestinal tract, is increasingly used to predict in vivo performance and to support formulation optimisation and biowaiver justification without recourse to additional clinical studies, while automated dissolution systems incorporating in-line ultraviolet fibre-optic probes are enabling real-time dissolution monitoring with reduced manual sampling error.
Additional Information
Frequently Asked Questions
**Q: **Why is dissolution testing considered most predictive of in vivo performance for Biopharmaceutics Classification System Class Two drugs?
**A: **Because Class Two drugs possess high intestinal permeability but low aqueous solubility, dissolution rate rather than membrane transport is typically the rate-limiting step governing oral absorption, so in vitro dissolution behaviour closely tracks in vivo absorption behaviour for this class.
**Q: **What is meant by sink conditions in dissolution testing?
**A: **Sink conditions describe a dissolution medium volume sufficient to keep the dissolved drug concentration well below its saturation solubility throughout testing, ensuring that the measured dissolution rate reflects the intrinsic release behaviour of the dosage form rather than being artificially limited by solubility saturation in the vessel.
Interview Questions
- Explain the difference between Apparatus One and Apparatus Two and the circumstances under which each would be selected.
- Describe the four classes of the biopharmaceutics classification system and their implications for formulation strategy.
Viva Questions
- Which apparatus configuration is most suitable for testing a floating capsule formulation?
- What is the highest and most valuable level of in vitro-in vivo correlation?
Chapter Summary
This chapter described the principal compendial dissolution apparatus configurations, the key considerations governing dissolution method development, the biopharmaceutics classification system, and the concept of in vitro-in vivo correlation, together illustrating how dissolution testing serves both as a routine quality control tool and as a predictive surrogate for in vivo drug absorption.